378 related articles for article (PubMed ID: 26626714)
1. Novel risk scores for survival and intracranial failure in patients treated with radiosurgery alone to melanoma brain metastases.
Chowdhury IH; Ojerholm E; McMillan MT; Miller D; Kolker JD; Kurtz G; Dorsey JF; Nagda SN; Geiger GA; Brem S; O'Rourke DM; Zager EL; Gangadhar T; Schuchter L; Lee JY; Alonso-Basanta M
Radiat Oncol; 2015 Dec; 10():248. PubMed ID: 26626714
[TBL] [Abstract][Full Text] [Related]
2. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
6. Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases.
Patel KR; Shoukat S; Oliver DE; Chowdhary M; Rizzo M; Lawson DH; Khosa F; Liu Y; Khan MK
Am J Clin Oncol; 2017 Oct; 40(5):444-450. PubMed ID: 26017484
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery.
Bian SX; Routman D; Liu J; Yang D; Groshen S; Zada G; Trakul N; Wong MK; Yu C; Chang EL
J Neurosurg; 2016 Dec; 125(Suppl 1):31-39. PubMed ID: 27903181
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
[TBL] [Abstract][Full Text] [Related]
10. Linear accelerator based stereotactic radiosurgery for melanoma brain metastases.
Bernard ME; Wegner RE; Reineman K; Heron DE; Kirkwood J; Burton SA; Mintz AH
J Cancer Res Ther; 2012; 8(2):215-21. PubMed ID: 22842364
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in patients treated with stereotactic image-guided robotic radiosurgery for brain metastases: a single-center retrospective analysis of 223 patients.
Pontoriero A; Conti A; Iatì G; Mondello S; Aiello D; Rifatto C; Risoleti E; Mazzei M; Tomasello F; Pergolizzi S; De Renzis C
Neurosurg Rev; 2016 Jul; 39(3):495-504. PubMed ID: 27106896
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
13. Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS.
Shultz DB; Modlin LA; Jayachandran P; Von Eyben R; Gibbs IC; Choi CYH; Chang SD; Harsh GR; Li G; Adler JR; Hancock SL; Soltys SG
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):993-999. PubMed ID: 26194677
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD
Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685
[TBL] [Abstract][Full Text] [Related]
15. Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery.
Kano H; Morales-Restrepo A; Iyer A; Weiner GM; Mousavi SH; Kirkwood JM; Tarhini AA; Flickinger JC; Lunsford LD
J Neurosurg; 2018 Jan; 128(1):14-22. PubMed ID: 28106495
[TBL] [Abstract][Full Text] [Related]
16. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.
Kirkpatrick JP; Wang Z; Sampson JH; McSherry F; Herndon JE; Allen KJ; Duffy E; Hoang JK; Chang Z; Yoo DS; Kelsey CR; Yin FF
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):100-8. PubMed ID: 25442342
[TBL] [Abstract][Full Text] [Related]
17. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
[TBL] [Abstract][Full Text] [Related]
18. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
[TBL] [Abstract][Full Text] [Related]
19. Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment.
Ly D; Bagshaw HP; Anker CJ; Tward JD; Grossmann KF; Jensen RL; Shrieve DC
J Neurosurg; 2015 Aug; 123(2):395-401. PubMed ID: 25768829
[TBL] [Abstract][Full Text] [Related]
20. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article.
Liew DN; Kano H; Kondziolka D; Mathieu D; Niranjan A; Flickinger JC; Kirkwood JM; Tarhini A; Moschos S; Lunsford LD
J Neurosurg; 2011 Mar; 114(3):769-79. PubMed ID: 20524829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
